"Synovial sarcoma (SS) is considered as high-grade tumors with a poor prognosis. Novel therapies targeted at fusion oncogene SS18-SSX-derived peptide vaccine epidermal growth factor receptor and vascular endothelial growth factor are the future hope in SS."xsd:string